Cargando…
Recent advances in the understanding and management of IgA nephropathy
Since its first description in 1968, IgA nephropathy has remained the most common form of primary glomerulonephritis leading to chronic kidney disease in developed countries. The clinical progression varies, and consequent end-stage renal disease occurs in 30% to 40% of patients 20 to 30 years after...
Autores principales: | Lai, Kar Neng, Leung, Joseph C.K., Tang, Sydney C.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755398/ https://www.ncbi.nlm.nih.gov/pubmed/26918170 http://dx.doi.org/10.12688/f1000research.7352.1 |
Ejemplares similares
-
Recent advances in managing and understanding diabetic nephropathy
por: Tang, Sydney C.W., et al.
Publicado: (2016) -
Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone
por: Leung, Joseph CK, et al.
Publicado: (2011) -
Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
por: Yiu, Wai Han, et al.
Publicado: (2021) -
Current treatment of IgA nephropathy
por: Floege, Jürgen, et al.
Publicado: (2021) -
Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)